Keep more.
Go further.
Clinical trial financing that helps you rely less on equity and keep more of what comes next.
Let’s talk ↗Trials cost money.
When you’re ready to test your science, you need money to run the trial. One common route is to raise it from investors. In return, they own part of your company.
That’s what selling equity means: giving up a share of your company to pay for the next step.
Raise money from investors.
Give them a share of your company.
Use the money to run your trial.
Borrow part of what you need.
Sell less of your company.
Use your tax refund to help repay the loan.
Sell less of your company.
P74 Bio can lend you part of the money for your trial. That means you may need to raise less from investors and can keep more ownership.
In some countries, you can claim back part of what you spend on eligible research each year. We lend against that expected refund, so you can access some of the money sooner. When the refund arrives, it goes towards repaying the loan.
Refunds depend on eligibility and an approved claim. Interest, fees and repayment terms apply.Why Australia?
If you qualify, Australia’s R&D tax incentive can give you back 43.5% of eligible research costs, assuming a 25% company tax rate.
You don’t have to start out as an Australian company. Overseas startups can explore whether an eligible Australian setup and trial would qualify.
Based in the UK or Canada? Those countries have their own R&D tax incentives for qualifying companies.
About Australia’s R&D tax incentive ↗Let’s chat
at Jefferies.
Tell us what you’re working on and where you are with your trial. We’ll talk through whether this could work for you.
Jeremy Sohn · Managing Partner